Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

8.78USD
1:30pm EDT
Change (% chg)

$-0.64 (-6.79%)
Prev Close
$9.42
Open
$9.32
Day's High
$9.55
Day's Low
$8.73
Volume
258,870
Avg. Vol
376,311
52-wk High
$11.15
52-wk Low
$4.27

PGNX.OQ

Chart for PGNX.OQ

About

Progenics Pharmaceuticals, Inc.is engaged in developing medicines for oncology. The Company completed Phase II clinical trials of two product candidates for prostate cancer, and resumed a pivotal Phase II trial of an ultra-orphan radiotherapy candidate for pheochromocytoma. Its principal clinical-stage product candidates in... (more)

Overall

Beta: 1.79
Market Cap(Mil.): $656.06
Shares Outstanding(Mil.): 69.64
Dividend: --
Yield (%): --

Financials

  PGNX.OQ Industry Sector
P/E (TTM): 147.03 36.15 39.84
EPS (TTM): 0.06 -- --
ROI: 2.46 16.37 15.61
ROE: 3.11 17.15 16.64
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks